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Abstract 
Background: Developmental stress has been hypothesised to interact with genetic predisposition to increase the 
risk of developing substance use disorders. Here we have investigated the effects of maternal separation-induced 
developmental stress using a behavioural proxy of methamphetamine preference in an animal model of attention-
deficit/hyperactivity disorder, the spontaneously hypertensive rat, versus Wistar Kyoto and Sprague–Dawley compara-
tor strains.
Results: Analysis of results obtained using a conditioned place preference paradigm revealed a significant 
strain × stress interaction with maternal separation inducing preference for the methamphetamine-associated com-
partment in spontaneously hypertensive rats. Maternal separation increased behavioural sensitization to the locomo-
tor-stimulatory effects of methamphetamine in both spontaneously hypertensive and Sprague–Dawley strains but 
not in Wistar Kyoto rats.
Conclusions: Our findings indicate that developmental stress in a genetic rat model of attention-deficit/hyperactiv-
ity disorder may foster a vulnerability to the development of substance use disorders.
Keywords: Addiction, Attention-deficit/hyperactivity disorder, Conditioned place preference, Developmental stress, 
Methamphetamine, Spontaneously hypertensive rat
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Background
Over recent years a substantial and compelling body 
of literature has emerged to suggest the importance of 
gene ×  environment interactions in the development of 
psychopathology. Genetic inheritance and environmental 
factors each account for approximately 50  % of the risk 
of developing a substance use disorder (SUD) [1]. More 
specifically, both human and animal studies have identi-
fied early life stress and a diagnosis of attention-deficit/
hyperactivity disorder (ADHD) as individual risk factors 
for the development of SUDs [2, 3]. Specific mechanisms 
involved in such vulnerability have begun to be delineated 
in humans. A [11C]raclopride positron emission tomog-
raphy study found that a history of childhood adversity 
increased amphetamine-induced dopamine release in the 
ventral striatum [4] while data from a functional mag-
netic resonance imaging (fMRI) study revealed increased 
limbic area activity after childhood maltreatment in 
abstinent methamphetamine-dependent individuals [5]. 
A further fMRI study examining reward-related brain 
areas found increased activity in the putamen in indi-
viduals who had experienced early life adversity whilst 
activity in the right insula was associated with ADHD 
symptomology [6]. Specific animal models may be use-
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isolation-induced developmental stress in rats was found 
to increase cocaine self-administration [7]. In a separate 
study, developmentally stressed rats displayed a reduced 
threshold for intracranial self-stimulation of the lateral 
hypothalamus following amphetamine administration, an 
indication that the reward-enhancing effect of ampheta-
mine was higher than in controls [8]. Combined these 
results suggest that early life stress and ADHD may ren-
der individuals hyper-sensitive to psychostimulants.
Though the shared pathophysiology underlying devel-
opmental stress, ADHD and SUDs is not yet clear, altered 
dopaminergic transmission affects all three processes and 
thus has emerged as a likely mechanism. Developmen-
tal stress induces long-term changes in the dopaminer-
gic system, reducing dopamine type 2 receptor levels in 
the nucleus accumbens, which is in turn associated with 
compulsive drug use and impulsivity [9–11]. Altered 
striatal concentrations and functional polymorphisms of 
the dopamine transporter (DAT), the presynaptic trans-
porter responsible for the rapid reuptake of synaptic 
dopamine and therefore of critical importance in dopa-
minergic homeostasis, have both been implicated in 
ADHD [12, 13]. Furthermore, the most widely prescribed 
medications for the treatment of ADHD are psychostim-
ulants, which exert their effects at dopaminergic synapses 
[14]. DAT is the molecular target for the psychostimulant 
drug of abuse, methamphetamine, which binds to DAT 
and reverses its action essentially causing dopamine to be 
released into, rather than taken up from, synapses [15]. 
The subsequent supraphysiological levels of dopamine 
are responsible for the rewarding properties of drugs 
and in turn influence a number of dopamine-dependent 
behavioural processes, which are comorbid with the 
development of SUDs, such as altered motivation, motor 
output, impulsivity and reward processing [10, 16].
To further probe the common mechanism underly-
ing developmental stress, ADHD and SUDs, we previ-
ously used in  vivo chronoamperometry to examine the 
effect of developmental stress, via maternal separation 
(MS), on striatal dopamine clearance in an animal model 
of ADHD. The spontaneously hypertensive rat (SHR), 
in comparison to its normotensive progenitor strain 
the Wistar Kyoto rat (WKY), is a well-validated animal 
model of ADHD [17–19]. Our preliminary results indi-
cated that MS delayed the clearance of ejected dopamine 
in SHR suggesting reduced DAT efficiency [20]. A further 
study examining the effect of cocaine, a psychostimulant 
and potent DAT inhibitor, in this model found that the 
cocaine-induced delay in dopamine uptake was exacer-
bated by MS in SHR resulting in a prolonged elevated 
dopamine concentration [21]. Given these results, we 
hypothesise that the observed decrease in DAT efficiency 
in MS SHR will translate into an increased preference for 
the psychostimulant methamphetamine, a drug with a 
high potential for dependence and abuse [22]. We exam-
ined this proposal using SHR, WKY and an additional 
comparator strain, Sprague Dawley (SD), to control for 
the putative depressive/anxious phenotype of WKY, 
which might influence our results [23, 24]. This study 
used adolescent rats, an age associated with the onset of 
drug use and prior to the full development of elevated 
blood pressure in SHR [25, 26]. We employed the condi-
tioned place preference (CPP) test, a classical condition-
ing paradigm that pairs drug exposure with one of two 
visually and tactilely distinct compartments to determine 
whether drug administration can overcome an innate 
initial preference. Successful pairing of a drug with the 
non-preferred compartment and a change in location 
preference is used as a proxy for the rewarding properties 
of the drug [27].
Methods
Animals
SHR (Charles River Laboratories, Wilmington, MA, 
USA), WKY (Harlan Laboratories, Bicester, UK) and SD 
(Charles River Laboratories, Wilmington, MA, USA) rats 
were obtained from strains maintained at the University 
of Cape Town Research Animal Facility. The decision to 
source WKY from Harlan, UK, rather than Charles River 
Laboratories, was based on research suggesting that they 
are the most appropriate behavioural and genetic control 
[24]. Rats had ad libitum access to water and standard rat 
chow and were housed in clear Perspex cages with wood 
chip bedding in a facility maintained at 21–23 °C with a 
12/12 h light/dark cycle (lights on at 06h00). All experi-
ments were authorised by the University of Cape Town 
Faculty of Health Sciences Animal Ethics Committee 
under application 011/047 and conformed to local and 
international standards set out for the care and use of 
animals for scientific purposes [28, 29].
Maternal separation
The MS paradigm was performed as previously described 
[30]. Briefly, male and female rats were pair bred in the 
University of Cape Town Human Biology satellite ani-
mal facility and the day of birth of the resulting litters 
was designated as postnatal day 0 (P0). On P2, the dam 
was removed from the cage and the number and sex of 
the pups was determined. In order to maintain uniform-
ity of care, litters were culled to 8 pups with males pref-
erentially selected for. However, a minimum of 2 female 
pups were retained in each litter to control for possible 
altered maternal behaviour and subsequent anxiety in 
offspring due to varying litter gender composition [31, 
32]. Dams of non-separated (nMS) litters were subse-
quently returned to the home cage and remained with 
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the litter in the animal facility until weaning. Conversely, 
on P2 MS litters were removed from the dam to a sepa-
rate room maintained at 31–33 °C with infrared heating 
lamps. Three hours later the litters were returned to the 
animal facility and the dam returned to the home cage. 
This separation paradigm occurred between 09h00 and 
13h00 over 13 days from P2 to P14. Cleaning of cages and 
the initial handling of pups on P2 was consistent across 
MS and nMS groups to ensure that potential differences 
would be due to the effect of the separation paradigm. 
On P21 litters were weaned and male rats we co-housed 
(2–4 rats/cage) for the remainder of the project. No more 
than 2 rats from any one litter were assigned to an experi-
mental group so as to avoid potential confounding litter 
effects.
Conditioned place preference
The CPP paradigm was performed over the course of 
7 days (P54–P60) in male adolescent rats, thereby corre-
sponding with the most common age of onset for SUDs 
in humans [33]. This compressed protocol consisted of 
3 preconditioning, 3 conditioning and 1 probe trial day. 
Briefly, a square black Perspex box (43 cm length × 50 cm 
height) was equally divided by a central partition to pro-
duce one chamber with a grid floor and thin vertical 
white stripes on the walls and a second chamber with 
unadorned walls and a smooth floor. Rats were allowed 
to freely explore the apparatus for 30 min during precon-
ditioning, which was performed over the course of 3 days 
to compensate for the increased exploratory drive and 
preference for novelty in SHR as well as potential anxi-
ety in WKY [34]. The compartment in which rats spent 
the most time on the 3rd day of testing was designated as 
the preferred compartment. The conditioning period was 
composed of 2 × 1-h trials per day with a vehicle (0.9 % 
saline administered via intraperitoneal injection at 1 ml/
kg volume) injection paired with the preferred compart-
ment, and a methamphetamine (Sigma-Aldrich, St Louis, 
MO, USA) injection (1.5 mg/kg in 0.9 % saline adminis-
tered via intraperitoneal injection at 1 ml/kg) paired with 
the non-preferred compartment. These 2 trials were sep-
arated by at least 3 h to allow sufficient time for memory 
formation with the non-drug pairing conducted first to 
prevent the association of potential withdrawal effects 
with the subsequent trial [27]. The selected dose of meth-
amphetamine (1.5  mg/kg calculated as a free base) was 
based on 3 factors: successful CPP in SHR following 
conditioning with a 1.25  mg/kg dose; the failure to find 
an effect of MS on place preference in SD rats adminis-
tered a 1.0 mg/kg dose; and the need to avoid potential 
neurotoxic side effects associated with a higher dose, 
which might reduce locomotor activity due to depressive 
effects [35–38]. As caudate putamen methamphetamine 
concentrations peak between 30 and 60 min post intra-
peritoneal injection, rats were injected 10  min prior to 
the onset of conditioning trials to ensure that peak cer-
ebral concentrations of methamphetamine were reached 
within the 1 h conditioning trial [39]. On the final day of 
testing, P60, rats were exposed to a 30  min probe trial 
during which they were allowed to freely explore the 
apparatus. Behaviour was recorded using a Soni Handi-
cam DCR-SX 83E and time spent in each compartment 
as well as locomotor activity were analysed using Nol-
dus Ethovision XT 7.0 (Noldus Information Technology, 
Wageningen, Netherlands). This experimental design 
produced 6 final groups: nMS SHR (n  =  13), MS SHR 
(n = 11), nMS WKY (n = 10), MS WKY (n = 13), nMS 
SD (n = 13) and MS SD (n = 10).
Statistical analyses
All data were tested for normal distribution using a Sha-
piro–Wilk W test. Baseline activity data over the course 
of the 3 preconditioning days was analysed to check for 
strain and stress effects. The time spent highly mobile 
(defined as the period of time during which the area 
detected as the animal changes by at least 60 % per sec-
ond) was non-parametrically distributed and there-
fore tested for potential strain  ×  stress effects using a 
Kruskal–Wallis test with multiple comparisons of mean 
ranks with Bonferroni adjustment as a post hoc test. To 
check for differences in the initial strength of compart-
ment preference, the duration spent in the non-preferred 
compartment on the third day of preconditioning was 
subjected to a factorial ANOVA with strain and stress 
as categorical predictors. Significant differences were 
further investigated using a Tukey post hoc test. Meth-
amphetamine preference scores were calculated by 
subtracting the time spent in the non-preferred com-
partment on the third day of preconditioning from 
the time spent in the same compartment during the 
probe trial. Therefore a positive value, i.e. increased 
time spent in the non-preferred compartment follow-
ing methamphetamine conditioning, was taken as an 
indication of increased preference for the drug-paired 
compartment. Preference scores were normally distrib-
uted and thus analysed using a factorial ANOVA with 
strain and stress as categorical factors. Significant differ-
ences between groups were probed using a Tukey post 
hoc test. To determine which groups displayed behav-
ioural sensitisation to methamphetamine, the total dis-
tance covered and the time spent highly mobile on the 
first and third days of conditioning were compared. As 
these data were non-parametrically distributed, they 
were analysed with a Wilcoxon Matched Pairs Test. To 
check for strain × stress effects on sensitisation, we sub-
jected the mobility data to an aligned rank transform for 
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nonparametric factorial analyses [40]. This preprocess-
ing allows common ANOVA procedures to be used to 
investigate interaction effects in repeated measures non-
parametrically distributed data. All statistical analyses 
were performed using Statistica 13 (Statsoft, Dell Soft-
ware, Tulsa, OK, USA) and an α value of 0.05 was used 
to determine significance. Graphs were generated using 
GraphPad Prism 6.0 (GraphPad, La Jolla, CA, USA).
Results
The time spent highly mobile was recorded over the 3 pre-
conditioning days and analysed to check for differences in 
baseline locomotor activity. Kruskal–Wallis tests revealed 
significant strain × stress effects on the time spent highly 
mobile on each of the 3 days [day 1 H(5,N = 70) = 23.47, 
p < 0.001; day 2 H(5,N = 70) = 22.43, p < 0.001; and day 
3 H(5,N = 70) = 26.27, p < 0.001] (Fig. 1). Post hoc analy-
sis revealed that MS WKY spent less time highly mobile 
than MS SHR across all 3  days (day 1 p =  0.022, day 2 
p = 0.020, and day 3 p = 0.013). MS WKY also spent less 
time highly mobile than MS SD on the third day of pre-
conditioning (p  =  0.009). Further differences between 
SHR and WKY rats were also found on days 2 and 3 
of preconditioning where nMS SHR spent more time 
highly mobile than nMS WKY (p = 0.020 and p = 0.039 
respectively).
The change in time spent in the non-preferred com-
partment following methamphetamine administration 
was analysed by factorial ANOVA and revealed a signifi-
cant strain x stress interaction (F(2,64) = 6.45, p = 0.003). 
A post hoc test indicated that MS SHR spent a longer 
period in the methamphetamine-paired compartment 
compared to both nMS SHR and MS SD (p  =  0.049 
and p  =  0.029 respectively) (Fig.  2). MS did not alter 
preference for the methamphetamine-paired compart-
ment in either WKY or SD and no strain difference was 
found within the nMS group. The strength of initial com-
partment preference was analysed by factorial ANOVA 
and revealed a significant strain effect (F(2,64)  =  10.36, 
p  <  0.001). A Tukey post hoc test indicated that WKY 
spent more time in the preferred compartment initially 
than both SHR and SD (p < 0.001 and p = 0.002 respec-
tively) (Fig. 2).
Potential sensitisation to methamphetamine was deter-
mined by comparing locomotor activity data obtained on 
the first and third days of methamphetamine condition-
ing. A Wilcoxon matched pairs test indicated an increase 
in time spent highly mobile on the third day of condi-
tioning for all groups (T(n=70) =  619.5, p  <  0.001). This 
difference was significant in nMS SHR (T(n=13)  =  8.0, 
p =  0.009), MS SHR (T(n=11) =  2.0, p =  0.006) and MS 
SD (T(n=10) = 4.0, p = 0.028) (Fig. 3). A further Wilcoxon 
matched pairs test revealed a significant effect of meth-
amphetamine on total distance covered in all groups 
(T(n=70) = 640.0, p < 0.001), which was due to MS SHR 
and MS SD covering significantly greater distances on the 
third day of conditioning (T(n=11) =  8.0, p =  0.026, and 
T(n=10) =  6.0, p =  0.028 respectively) (Fig.  4). Repeated 
measures ANOVAs of aligned rank transformed data 
revealed no significant strain  ×  stress effects for either 
the duration highly mobile or the total distance covered.
Discussion
In this study we sought to investigate whether our ear-
lier observation of delayed dopamine reuptake in MS 
SHR translates into increased preference for the psy-
chostimulant methamphetamine measured using a CPP 
paradigm. Consistent with our hypothesis, MS SHR dis-
played increased preference for the methamphetamine-
paired compartment compared to both nMS SHR and 
MS SD. The failure of MS in SD rats to increase metham-
phetamine preference is consistent with a previous study, 
in which nMS and MS male SD rats were exposed to 2 
conditioning stages (P33–36 and P39–42) with meth-
amphetamine (administered at 1 mg/kg) yet did not dif-
fer in their preference for methamphetamine at P37, 
P43 or P50 [35]. The finding that WKY did not develop 
methamphetamine CPP is also in keeping with a previ-
ous study that showed that rats with high anxiety exhibit 
less 50  kHz ultrasonic vocalizations—a marker of posi-
tive affect [41]. We also investigated whether there were 
any differences in the initial magnitude of compartment 
preference and determined that WKY showed a more 
robust preference for the saline-paired compartment 
during preconditioning than both SHR and SD rats. Per-
haps more importantly for the current results, there was 
no difference in the strength of compartment preference 
Fig. 1 SHR and WKY rats exhibit baseline differences in the time 
spent highly mobile during preconditioning. ^MS WKY spent less 
time highly mobile compared to MS SHR on days 1 through 3 of 
preconditioning and compared to MS SD on the third day of precon-
ditioning (p < 0.05, Bonferroni post hoc test). *nMS WKY spent less 
time highly mobile than nMS SHR during the second and third days 
of preconditioning (p < 0.05, 613 Bonferroni post hoc test). Data are 
displayed as median and interquartile range
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between nMS and MS SHR. Combined these results sug-
gest that the influence of developmental stress on drug 
preference is dependent on genetic predisposition.
The failure of nMS SHR to show a robust preference 
for the methamphetamine-associated compartment is 
perhaps surprising given the association between ADHD 
and drug abuse [42]. However, we maintain that previ-
ous studies which found that SHR exhibit a preference 
for psychostimulants differ from our own in several 
important methodological aspects including the source 
of the SHR used and the age at testing. For example, 
several studies in SHR have found positive preference 
for methamphetamine (1.25 and 5.0  mg/kg) as well as 
the psychostimulants amphetamine (5 mg/kg) and meth-
ylphenidate (1.25, 5.0 and 20  mg/kg) [37, 38, 43, 44]. 
Importantly, these studies made use of SHR obtained 
from Charles River Japan as opposed to the current study 
which sourced SHR from Charles River USA, a notewor-
thy distinction given evidence that suggests that SHR 
from different vendors may display different behavioural 
Fig. 2 MS SHR displayed preference for the methamphetamine-paired compartment. *The difference in time spent in the non-preferred/meth-
amphetamine-paired compartment between the third day of preconditioning and the probe trial was greater in MS SHR than nMS SHR and MS SD 
(p < 0.05, Tukey post hoc test). ^WKY displayed a stronger initial preference for the preferred compartment than both SHR and SD (p < 0.05, Tukey 
post hoc test). Data are displayed as mean ± SEM
Fig. 3 SHR spent more time highly mobile after repeated metham-
phetamine administration. *nMS SHR, MS SHR and MS SD spent more 
time highly mobile on the third day of conditioning than on the first 
day (p < 0.05, Wilcoxon matched pairs test). Results are displayed as 
median and interquartile range Fig. 4 MS increased locomotor activity after repeated methampheta-
mine administration in SHR and SD rats. *MS SHR and SD travelled 
further on day 3 than on day 1 (p < 0.05, Wilcoxon matched pairs 
test). Results are displayed as median and interquartile range
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characteristics [24]. Furthermore, in the aforementioned 
studies, the age of the rats at the time of behavioural test-
ing differed by at least a week compared to our protocol. 
Though a small difference, age has previously been sug-
gested to influence the response to psychostimulants in 
SHR [45, 46]. A further possible reason for the failure 
to find methamphetamine CPP in nMS SHR in the cur-
rent study lies in the behaviour of the strain. Previous 
research has indicated that, congruent with the hyperac-
tive phenotype, SHR continue to display increased loco-
motor activity in familiar environments [47]. Indeed, an 
analysis of preconditioning baseline activity revealed that 
SHR were more active than their WKY counterparts. It is 
therefore possible that the rewarding effects of metham-
phetamine were insufficient to prevent nMS SHR from 
exploring both chambers of the apparatus during the 
probe trial.
A repeated measures analysis of the locomotor activ-
ity on the first and third days of conditioning found no 
significant strain  ×  stress effects on the magnitude of 
sensitisation. However, a matched pairs comparison of 
locomotor activity on the first and third days of condi-
tioning indicated that nMS SHR, MS SHR and MS SD 
spent more time highly mobile after repeated meth-
amphetamine administration, which translated into an 
increased total distance covered in the latter two experi-
mental groups. As these results measure the change in 
locomotor activity due to methamphetamine, they are 
not influenced by the higher baseline activity levels of 
SHR. This suggests that SHR, and in particular MS SHR, 
display an increased sensitisation to methamphetamine 
i.e. repeated exposure produces an increased stimulant 
drug response that is associated with increased motiva-
tion to consume the drug [48]. The current study made 
use of ambulatory activity to measure locomotor sensiti-
sation. However, repeated exposure to psychostimulants 
may also lead to the development of repetitive motor 
behaviours or stereotypies such as repeated sniffing, 
rearing, and head and mouth movements [49]. Previ-
ous research using Lewis and Fischer 344 rats has indi-
cated that the developmental time course of stereotyped 
behaviour in response to methamphetamine may differ 
between strains [50]. Furthermore, a study comparing 
the behavioural responses of 6 week old SHR and WKY 
to d-amphetamine found strain differences in the types of 
stereotypic movement produced [51]. It is therefore pos-
sible that an analysis of stereotyped behaviour in the cur-
rent study may have revealed further strain and/or stress 
effects, including sensitisation to methamphetamine in 
WKY.
Comparison of the methamphetamine preference and 
sensitisation results reveal a conflict insofar as meth-
amphetamine elicited preference in MS SHR whilst 
increasing sensitisation in nMS SHR, MS SHR and MS 
SD. This apparent contradiction between psychomo-
tor and reward responses to psychostimulants has also 
been found in previous studies. One such investigation 
examined the effect of self-administration duration on 
drug-primed reinstatement and behavioural sensitisation 
[52]. Rats that advanced from short to extended access 
durations (1 vs. 6 h) escalated their cocaine consumption 
during the first hour of their trials such that they infused 
more cocaine in that period than their short access (1 h 
only) counterparts [52]. However, this group that dis-
played increased drug self-administration, a measure of 
drug preference, did not differ in locomotor sensitisation 
to the drug. Further, in a study that assessed locomotor 
activation, sensitisation and place preference in response 
to cocaine in 6 mouse strains, the authors failed to find 
locomotor sensitisation in certain strains that displayed 
drug CPP [53]. This led the authors to hypothesise that 
the psychomotor and rewarding effects of drugs may be 
served by distinct mechanisms. Extending this hypoth-
esis to our own results, it is possible that developmental 
stress may exert different effects on these mechanisms 
within the strains we tested. Support for this explanation 
is provided by previous research suggesting that the time 
course of dopaminergic development differs between 
SHR and comparator strains. In an in  vitro autoradiog-
raphy study assessing striatal dopaminergic development 
in pre- and post-hypertensive (2 and 15 week old respec-
tively) SHR and WKY, DAT was elevated in the caudate 
putamen of SHR at both developmental stages [54]. In 
addition, SHR putamen followed a lateral-to-medial DAT 
gradient during early development and displayed elevated 
dopamine type 1 receptor concentrations compared to 
WKY by 15 weeks [54]. A further study examining [3H]
dopamine uptake into synaptosomes prepared from 
WKY and SHR (at 1, 2, 3, 6, 8 and 10 weeks of age) found 
that the rate of dopamine uptake in the prefrontal cortex 
was persistently lower in SHR from 2 weeks onwards and 
transiently lower in the striatum at the 6 week time point 
[55]. Though we were unable to find reports evaluating 
dopaminergic development in SHR and SD strains, the 
comparisons between SHR and WKY suggest possible 
strain differences in the developmental course of multiple 
dopaminergic pathways. It is therefore possible that the 
effects of MS may be region specific in different strains, 
based on the developmental stage of a particular brain 
area. In this way, MS may affect brain areas responsible 
for both locomotor activity and reward in SHR, whilst 
having a more anatomically restricted effect in influenc-
ing only locomotor activity in SD.
The potential of early life stress to exert long term 
changes on neurophysiology is well-recognised [56]. 
Of relevance to our MS model, immunohistochemical 
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studies have indicated that development of the stri-
atal dopaminergic system continues postnatally with an 
increase in axospinous connections and a decrease in 
axodendritic and axosomatic synapses [57]. The overall 
reduction in total dopaminergic synaptic density bears a 
closer resemblance to the adult profile [57]. Disruption 
during this critical window may produce psychopathol-
ogy associated with dopaminergic dysfunction including 
ADHD and SUDs [58–60].
Both increased locomotor activity in response to 
methamphetamine and successful place preference are 
dependent on dopamine and as such these two measures 
can be used as a proxy of increased extracellular dopa-
mine concentration [16, 61]. Given the preference for and 
sensitisation to methamphetamine displayed by MS SHR, 
it is likely that developmental stress in SHR increased the 
extracellular dopamine concentration in the brain areas 
serving these functions. This would also be in keeping 
with our previous in  vivo chronoamperometric stud-
ies where the DAT-mediated clearance of dopamine was 
delayed by MS in SHR [20, 21]. We hypothesise that the 
dose of methamphetamine used in the study (1.5 mg/kg) 
was non-saturating i.e. the number of DATs unimpeded 
by methamphetamine was reduced in MS SHR compared 
to controls. This scenario could result in a similar dopa-
mine release between groups but prolonged elevated 
synaptic dopamine in MS SHR due to reduced DAT-
mediated clearance. This is consistent with evidence 
for altered DAT function and responsiveness to psy-
chostimulants in ADHD as found by Stein et  al., where 
children diagnosed with ADHD and possessing the 9/9 
repeat DAT allele were less sensitive to the effects of the 
therapeutic psychostimulants on measures of hyperactiv-
ity and impulsivity [62]. However, further experiments 
measuring methamphetamine-induced dopamine release 
and DAT-mediated reuptake would be required to either 
support or refute this proposed mechanism. This hypoth-
esis would also be further refined by an experiment that 
examines whether MS affects DAT expression differently 
in SHR compared to WKY and SD.
Conclusions
Our finding of preference for the methamphetamine-
associated compartment in MS SHR strongly supports 
our previous chronoamperometric findings of reduced 
DAT-mediated dopamine clearance in MS SHR. Given 
the high cost of SUDs to individuals and society, such 
mechanistic insights are important in understanding 
how a diagnosis of ADHD and a history of develop-
mental stress may increase the risk of developing SUDs. 
Furthermore, these results again reinforce the impor-
tance of gene × environment interactions in influencing 
psychopathology.
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